Gilead Sciences is an American biotechnology company that develops and sells medicines. Founded in 1987 by a 29 year old doctor named Michael L. Riordan. Since its inception, it has specialized primarily in antiviral drugs for the treatment of patients with HIV, hepatitis B and similar diseases. This direction was not chosen by chance. The fact is that the founder of the company, Michael L. Riordan, while working in the Philippines, fell ill with an incurable viral disease - dengue fever, which gradually undermined his strength over the next years.
In 1999, Gilead Sciences expands its activities and acquires one after another companies involved in the production of medicines for pulmonary diseases. To date, the list of products manufactured by the company and available for sale includes 14 positions. But one of the most important achievements of Gilead Sciences so far is Truvada. Its components are able to change the genetic material of HIV before it combines with the genetic code of the infected cell, thus preventing the development of the disease.
Today, Gilead Sciences can boast of being one of the fastest growing companies in its field. Its headquarters is in California, but the company has offices in other states of North America, as well as in Europe and Australia.